0001209191-17-031930.txt : 20170512 0001209191-17-031930.hdr.sgml : 20170512 20170512161732 ACCESSION NUMBER: 0001209191-17-031930 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170510 FILED AS OF DATE: 20170512 DATE AS OF CHANGE: 20170512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nicholson Garry A CENTRAL INDEX KEY: 0001640861 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 17838865 MAIL ADDRESS: STREET 1: C/O TESARO, INC. STREET 2: 1000 WINTER STREET, SUITE 3300 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-10 0 0001175505 FIVE PRIME THERAPEUTICS INC FPRX 0001640861 Nicholson Garry A TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (right to buy) 29.80 2017-05-10 4 A 0 15000 0.00 A 2027-05-09 Common Stock 15000 15000 D The shares underlying this option vest at a rate of one-third per year on each anniversary of May 10, 2017, subject to the reporting person's continued service to Five Prime Therapeutics, Inc. through each such date. /s/ Francis Sarena, Attorney-in-fact 2017-05-12